Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Bristol-Myers Squibb (BMY) Tops Q1 EPS by 23c, Affirms EPS Guidance
May 7, 2020 7:01 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.72, $0.23 better than the analyst estimate of $1.49. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.02 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2020 EPS of $6.00-$6.20, versus the consensus of $6.17.... More



